Colony Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000	Closed	-$224K	–	807
2021 Q3	$224K	Hold	2,000	–	–	﹤0.01%	771
2021 Q2	$324K	Hold	2,000	–	–	0.01%	616
2021 Q1	$244K	Buy	+2,000	New	+$244K	0.01%	680